Cerebral Physiology and Pathophysiology Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Cerebral Physiology and Pathophysiology. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 1: What is the effect of moderate exercise on cerebral blood flow?
- A. Decreases
- B. Initially decreases then increases
- C. Increases (Correct Answer)
- D. Does not change
Cerebral Physiology and Pathophysiology Explanation: ***Increases***
- Moderate exercise leads to an **increase in systemic arterial pressure** and an increase in **cardiac output**, which often results in a moderate increase in cerebral blood flow.
- This increase is also attributed to **vasodilation of cerebral arteries** in response to metabolic demands and changes in blood gas levels during exercise.
*Decreases*
- A decrease in cerebral blood flow is generally associated with conditions leading to **hypoperfusion** or **severe vasoconstriction**, which are not typical effects of moderate exercise.
- While extreme exercise could potentially cause some transient vasoconstriction, moderate exercise typically has the opposite effect due to compensatory mechanisms.
*Initially decreases then increases*
- There is generally no physiological mechanism by which moderate exercise would cause an initial decrease in cerebral blood flow followed by an increase.
- Cerebral autoregulation usually maintains a stable blood flow, and the overall trend with moderate exercise is an increase.
*Does not change*
- While **cerebral autoregulation** aims to keep cerebral blood flow stable over a range of blood pressures, moderate exercise often pushes parameters (like CO2 levels and systemic pressure) enough to cause a measurable, albeit modest, **increase in blood flow**.
- The brain's metabolic demand also increases during exercise, necessitating an increased blood supply.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 2: Cerebral blood flow is regulated by all of the following except:
- A. Calcium ions (Correct Answer)
- B. Blood pressure
- C. Arterial PCO2
- D. Potassium ions
Cerebral Physiology and Pathophysiology Explanation: ***Calcium ions***
- While **calcium ions (Ca²⁺)** are mechanistically essential for vascular smooth muscle contraction and relaxation, they are **not considered a primary regulatory signal** for cerebral blood flow (CBF) in the same way as the other factors listed.
- Ca²⁺ acts as an **intracellular second messenger** that mediates the effects of other regulatory factors (like PCO2, K⁺, and vasoactive substances), rather than being a direct extracellular regulatory signal itself.
- The question refers to primary regulatory factors that directly modulate CBF, not the intracellular mechanisms by which vascular smooth muscle responds.
*Blood pressure*
- **Cerebral autoregulation** maintains relatively constant CBF despite changes in **mean arterial pressure (MAP)** between approximately 60-150 mmHg.
- Blood pressure is a **key regulatory factor** - when MAP falls below or exceeds this range, CBF becomes pressure-dependent.
- This protective mechanism prevents cerebral ischemia or hyperemia with systemic blood pressure fluctuations.
*Arterial PCO2*
- **Arterial partial pressure of carbon dioxide (PaCO2)** is one of the **most potent direct regulators** of CBF.
- **Hypercapnia** (increased PaCO2) causes cerebral vasodilation and increased CBF (approximately 1-2 mL/100g/min increase per 1 mmHg rise in PaCO2).
- **Hypocapnia** (decreased PaCO2) causes vasoconstriction and reduced CBF, utilized therapeutically in managing elevated intracranial pressure.
*Potassium ions*
- **Increased extracellular K⁺** in the perivascular space causes **direct vasodilation** of cerebral arterioles.
- This mechanism is crucial for **neurovascular coupling** (functional hyperemia) - when neurons are active, they release K⁺, which dilates nearby vessels to increase local blood flow.
- K⁺-mediated vasodilation helps match cerebral perfusion to metabolic demand during neuronal activity.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 3: The earliest manifestation of increased intracranial pressure following head injury is:
- A. Hemiparesis
- B. Ipsilateral pupillary dilatation
- C. Altered mental status (Correct Answer)
- D. Contralateral pupillary dilatation
Cerebral Physiology and Pathophysiology Explanation: ***Altered mental status***
- **Altered mental status** (e.g., confusion, irritability, drowsiness) is often the earliest sign of increased intracranial pressure (ICP) due to its profound effect on global brain function.
- This change reflects the **brain's reduced perfusion** and metabolic compromise as pressure within the rigid skull rises.
*Hemiparesis*
- **Hemiparesis** indicates focal neurological deficits, usually resulting from direct injury or significant pressure on specific motor pathways, which typically manifest later than global mental status changes.
- It suggests a more advanced stage of neurological compromise or a localized mass effect.
*Ipsilateral pupillary dilatation*
- **Ipsilateral pupillary dilatation** is a classic sign of uncal herniation, where the temporal lobe compresses the **oculomotor nerve** (CN III) on the same side.
- While critical, it is generally a *late and ominous sign* of significantly elevated ICP, indicating severe brainstem compression.
*Contralateral pupillary dilatation*
- **Contralateral pupillary dilatation** is highly unusual in the context of typical uncal herniation, which almost always causes *ipsilateral* signs due to direct compression.
- Its presence would suggest atypical herniation patterns or other causes of pupillary asymmetry.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 4: Anesthetic agent (s) safe to use in ICP
- A. Ketamine
- B. Thiopentone (Correct Answer)
- C. Halothane
- D. Ether
Cerebral Physiology and Pathophysiology Explanation: ***Thiopentone***
- **Thiopentone** is an ultrashort-acting barbiturate that reduces cerebral blood flow and cerebral metabolic rate, leading to a decrease in **intracranial pressure (ICP)**.
- It rapidly depresses brain activity, which directly lowers the demand for oxygen and nutrients, thus decreasing the blood volume within the cranium.
*Ketamine*
- **Ketamine** is known to increase cerebral blood flow and cerebral metabolic rate, which can lead to an undesirable **increase in ICP**.
- It causes cerebral vasodilation, which in patients with compromised intracranial compliance can worsen cerebral edema and raise ICP.
*Halothane*
- **Halothane** is a potent volatile anesthetic that causes significant **cerebral vasodilation**, leading to an increase in cerebral blood flow and potentially elevated **ICP**.
- Its use has largely declined due to its dose-dependent cerebral vasodilation and potential for myocardial depression.
*Ether*
- **Ether** is an old inhaled anesthetic agent that causes marked **cerebral vasodilation** and increased cerebral blood flow, thereby elevating **ICP**.
- It also has a slow onset and offset of action and is highly flammable, making it unsuitable for modern anesthesia, especially in neurosurgical contexts.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 5: Which of the following drugs is contraindicated in a patient with raised intracranial pressure ?
- A. Ketamine (Correct Answer)
- B. Midazolam
- C. Propofol
- D. Thiopentone
Cerebral Physiology and Pathophysiology Explanation: ***Ketamine***
- **Ketamine** typically causes an increase in **cerebral blood flow** and **intracranial pressure (ICP)**, making it contraindicated in patients with raised ICP.
- This effect is due to its action as a **dissociative anesthetic** which can lead to cerebral vasodilation.
*Midazolam*
- **Midazolam**, a benzodiazepine, can decrease **cerebral metabolic rate** and **cerebral blood flow**, thereby reducing ICP, making it a suitable option for sedation in patients with raised ICP.
- It provides **sedation** and **anxiolysis** without significantly increasing ICP.
*Propofol*
- **Propofol** is a common choice for sedation in patients with raised ICP because it significantly reduces **cerebral blood flow**, **cerebral metabolic rate**, and thus **intracranial pressure**.
- Its rapid onset and offset allow for precise control of depth of sedation and neurological assessment.
*Thiopentone*
- **Thiopentone**, a barbiturate, effectively reduces **cerebral blood flow** and **cerebral metabolic rate**, leading to a decrease in **intracranial pressure**.
- It is often used for inducing anesthesia and as a neuroprotective agent in situations with acute brain injury.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 6: All of the following causes decrease in CMRO2, CBF and ICP except:-
- A. Etomidate
- B. Propofol
- C. Thiopentone
- D. Ketamine (Correct Answer)
Cerebral Physiology and Pathophysiology Explanation: ***Ketamine***
- Ketamine is a dissociative anesthetic that typically causes an **increase in cerebral blood flow (CBF)** and **intracranial pressure (ICP)**, while its effect on cerebral metabolic rate of oxygen (CMRO2) can be variable but often does not decrease significantly.
- It works by antagonizing **NMDA receptors**, inducing a state of dissociation rather than global cerebral depression.
*Etomidate*
- Etomidate is an anesthetic agent that effectively **decreases CMRO2, CBF, and ICP**, making it suitable for neurosurgical procedures.
- Its mechanism involves enhancing **GABA-A receptor activity**, leading to global central nervous system depression.
*Propofol*
- Propofol is a commonly used intravenous anesthetic that significantly **reduces CMRO2, CBF, and ICP**.
- It primarily acts on **GABA-A receptors** to induce sedation and anesthesia, making it a good choice for patients with elevated ICP.
*Thiopentone*
- Thiopentone, a barbiturate, is known to produce a dose-dependent decrease in **CMRO2, CBF, and ICP**.
- It also enhances **GABA-A receptor-mediated inhibition**, resulting in cerebral vasoconstriction and metabolic suppression.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 7: Intracranial pressure may be increased by all of the following drugs except -
- A. Quinolones
- B. Aminoglycosides (Correct Answer)
- C. Vitamin A
- D. Corticosteroids
Cerebral Physiology and Pathophysiology Explanation: ***Aminoglycosides***
- **Aminoglycosides** are not typically associated with increasing intracranial pressure. Their primary toxicities include **ototoxicity** and **nephrotoxicity**.
- There is no established physiological mechanism by which aminoglycosides directly elevate ICP.
*Vitamin A*
- **Vitamin A toxicity**, particularly the chronic form of hypervitaminosis A, is a known cause of **idiopathic intracranial hypertension (pseudotumor cerebri)**, which directly increases ICP.
- This occurs due to an unknown mechanism that leads to impaired CSF absorption or increased CSF production.
*Corticosteroids*
- While corticosteroids are often used to reduce cerebral edema and ICP, their **withdrawal**, particularly after prolonged use, can lead to rebound increases in ICP.
- In certain susceptible individuals, or with paradoxical reactions, corticosteroids can also induce **pseudotumor cerebri**, leading to elevated ICP.
*Quinolones*
- **Quinolones** (fluoroquinolones) have been implicated in cases of **drug-induced intracranial hypertension (pseudotumor cerebri)**.
- The mechanism is not fully understood but is thought to involve effects on **cerebrospinal fluid dynamics**.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 8: Cushing reflex is associated with all except?
- A. Irregular respiration
- B. Hypotension (Correct Answer)
- C. Increased intracranial pressure
- D. Bradycardia
Cerebral Physiology and Pathophysiology Explanation: ***Hypotension***
- The **Cushing reflex** is a compensatory response to increased intracranial pressure (ICP) aiming to maintain cerebral perfusion, which typically involves **hypertension**, not hypotension.
- While prolonged or severe ICP can lead to decompensation and eventual hypotension, it is not a direct component of the reflex itself.
*Increased intracranial pressure*
- The **Cushing reflex** is triggered by an elevation in **intracranial pressure (ICP)**, as the body attempts to maintain blood flow to the brain.
- This increased ICP reduces cerebral perfusion pressure, prompting a systemic response to raise mean arterial pressure.
*Bradycardia*
- **Bradycardia** is a classic component of the **Cushing reflex**, occurring as a compensatory response to the reflex hypertension.
- The increased arterial blood pressure stimulates carotid and aortic baroreceptors, leading to a vagal response that slows the heart rate.
*Irregular respiration*
- **Irregular respiration** is another key component of the **Cushing reflex**, often manifesting as **Cheyne-Stokes breathing** or **ataxic breathing**.
- This respiratory dysregulation is due to direct compression and dysfunction of the brainstem, specifically the medullary respiratory centers, caused by increased ICP.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 9: When blood pressure falls below 40 mm Hg, which mechanism of regulation is working?
- A. CNS ischemic reflex (Correct Answer)
- B. Chemoreceptor response
- C. Baroreceptor response
- D. None of the options
Cerebral Physiology and Pathophysiology Explanation: ***CNS ischemic reflex***
- The **CNS ischemic reflex** is activated when blood pressure falls below 60 mmHg, with maximal activation below 40 mmHg, indicating severe ischemia in the brain's vasomotor center.
- This reflex elicits an intense **sympathetic vasoconstriction** and cardiac stimulation to prioritize blood flow to the brain even at the expense of other organs.
*Chemoreceptor response*
- The chemoreceptor reflex is primarily activated by a decrease in **arterial pO2**, an increase in **pCO2**, or a decrease in **pH**.
- While it can increase blood pressure, it is not the primary or most profound regulatory mechanism specifically triggered by extremely low blood pressure (below 40 mmHg) to prevent brain ischemia.
*Baroreceptor response*
- **Baroreceptors** are most sensitive to changes in blood pressure within the normal to moderately hypotensive range (e.g., 60-180 mmHg).
- At very low pressures (below 40-50 mmHg), baroreceptors become **less sensitive** or "saturated," and their effectiveness in raising blood pressure significantly diminishes.
*None of the options*
- This option is incorrect because the **CNS ischemic reflex** specifically functions as a powerful, last-ditch mechanism to maintain cerebral blood flow during severe hypotension which is a life saving reflex during conditions like hemorrhage.
Cerebral Physiology and Pathophysiology Indian Medical PG Question 10: Which of the following is the best cerebroprotective drug?
- A. Propofol
- B. Thiopentone (Correct Answer)
- C. Etomidate
- D. Ketamine
Cerebral Physiology and Pathophysiology Explanation: ***Thiopentone***
- **Thiopentone** is a barbiturate that can significantly reduce cerebral metabolic rate for oxygen (**CMRO2**) and cerebral blood flow (**CBF**), leading to a reduction in intracranial pressure (**ICP**).
- It achieves neuroprotection by decreasing brain metabolism, scavenging free radicals, and stabilizing neuronal membranes.
*Propofol*
- **Propofol** also reduces **CMRO2** and **CBF**, thus decreasing **ICP**, but its neuroprotective effects are less profound and consistent compared to barbiturates like thiopentone.
- While it has some neuroprotective properties, such as antioxidant effects, it is not considered the **best** cerebroprotective agent, especially in severe cases where maximum cerebral protection is needed.
*Etomidate*
- **Etomidate** is known for its minimal cardiovascular effects and its ability to reduce **CMRO2** and **CBF**, which can lower **ICP**.
- However, its use is limited by its potential to cause adrenal suppression with prolonged or repeated administration, making it less suitable for continuous cerebroprotection.
*Ketamine*
- **Ketamine** typically increases **CBF** and **CMRO2**, which can lead to an increase in **ICP**, making it generally unsuitable as a cerebroprotective agent in patients with elevated ICP or acute cerebral injury.
- While it has analgesic and dissociative properties, its impact on cerebral hemodynamics often contraindicates its use in situations requiring brain protection.
More Cerebral Physiology and Pathophysiology Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
